However, IGF-1 failed to increase the level of Brk phosphorylation or activate Brk kinase activity in T47D breast cancer cells [25]; IGF-1 effects may have gone undetected due to high basal Brk activity in these cells (Fig. 1C). The gene discussed is PTK6; the disease is breast cancer.